Xenon Pharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 7.53 M | $294.99 M | 8.78% | 9.66% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 5.67 M | $222.13 M | 0.00% | 7.27% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.52 M | $177.21 M | -1.63% | 5.80% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 3.78 M | $148.08 M | -1.71% | 4.85% |
BRAIDWELL LP | 02/14/2025 | 2.91 M | $114.23 M | 7.64% | 3.74% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.87 M | $112.43 M | 12.32% | 3.68% |
COMMODORE CAPITAL LP | 02/14/2025 | 2.74 M | $107.41 M | 1.48% | 3.52% |
POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 2.70 M | $105.75 M | 10.35% | 3.46% |
CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 2.55 M | $99.85 M | -1.32% | 3.27% |
CAPITAL WORLD INVESTORS | 02/13/2025 | 2.29 M | $89.95 M | -14.43% | 2.94% |
BLACKROCK, INC. | 02/07/2025 | 2.11 M | $82.53 M | -0.02% | 2.70% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.86 M | $73.05 M | -10.58% | 2.39% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.50 M | $58.66 M | -2.11% | 1.92% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.44 M | $56.57 M | 1.29% | 1.85% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 1.44 M | $56.36 M | -4.39% | 1.85% |
JPMORGAN CHASE & CO | 02/12/2025 | 1.36 M | $53.19 M | 38.91% | 1.74% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.25 M | $49.07 M | -4.91% | 1.61% |
AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 1.16 M | $45.52 M | 1.50% | 1.49% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 1.16 M | $45.49 M | -1.78% | 1.49% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2025 | 1.16 M | $45.36 M | 72.82% | 1.49% |
SAMLYN CAPITAL, LLC | 02/14/2025 | 1.02 M | $39.90 M | -0.23% | 1.31% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 993,679 | $38.95 M | 0.00% | 1.28% |
ORBIMED ADVISORS LLC | 02/14/2025 | 947,877 | $37.16 M | 4.00% | 1.22% |
MARSHALL WACE, LLP | 02/13/2025 | 899,718 | $35.27 M | -24.74% | 1.15% |
TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/03/2025 | 848,850 | $33.27 M | 9.07% | 1.09% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 810,000 | $31.75 M | -1.82% | 1.04% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 801,553 | $31.42 M | 39.00% | 1.03% |
SIREN, L.L.C. | 02/14/2025 | 743,769 | $29.16 M | 0.00% | 0.95% |
LOOMIS SAYLES & CO L P | 02/12/2025 | 687,145 | $26.94 M | -2.84% | 0.88% |
FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 684,986 | $26.85 M | 110.62% | 0.88% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 663,704 | $26.02 M | 51.16% | 0.85% |
02/14/2025 | 600,000 | $23.52 M | 100.00% | 0.77% | |
FRANKLIN RESOURCES INC | 02/12/2025 | 575,590 | $22.56 M | 1.71% | 0.74% |
FEDERATED HERMES, INC. | 02/13/2025 | 558,500 | $21.89 M | -24.14% | 0.72% |
FIERA CAPITAL CORP | 01/29/2025 | 535,887 | $21.01 M | -3.30% | 0.69% |
CANDRIAM S.C.A. | 02/07/2025 | 492,181 | $19.29 M | 6.11% | 0.63% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 474,000 | $18.58 M | -42.05% | 0.61% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 410,246 | $16.08 M | -10.74% | 0.53% |
STEMPOINT CAPITAL LP | 02/14/2025 | 375,845 | $14.73 M | 100.00% | 0.48% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 346,040 | $13.56 M | 65.55% | 0.44% |
VANGUARD GROUP INC | 02/11/2025 | 342,779 | $13.44 M | -0.46% | 0.44% |
CITADEL ADVISORS LLC | 02/14/2025 | 327,303 | $12.83 M | -54.70% | 0.42% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 325,324 | $12.75 M | -38.03% | 0.42% |
SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 322,470 | $12.64 M | 100.00% | 0.41% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 298,700 | $11.71 M | 9.13% | 0.38% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 288,843 | $11.32 M | 0.00% | 0.37% |
STATE STREET CORP | 02/14/2025 | 288,722 | $11.32 M | 3.29% | 0.37% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 288,000 | $11.29 M | -20.13% | 0.37% |
ABRDN PLC | 01/24/2025 | 283,899 | $11.13 M | 14.33% | 0.36% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 273,739 | $10.73 M | 0.00% | 0.35% |
Xenon Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 240 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc.. The most heavily invested institutionals were:
FMR LLC: 7.53 M
Avoro Capital Advisors LLC: 5.67 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 4.52 M
WELLINGTON MANAGEMENT GROUP LLP: 3.78 M
BRAIDWELL LP: 2.91 M
JANUS HENDERSON GROUP PLC: 2.87 M
97.90% of Xenon Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 81.25 M shares in the last 24 months. This purchase volume represents approximately $2.49 B in transactions.